The distinctive micromegakaryocytes of transformed chronic myeloid leukemia

N. Fordham,S. Stern,J. Swansbury,B. Bain
DOI: https://doi.org/10.1002/ajh.24290
2016-03-01
Abstract:A 41-year-old Afro-Caribbean woman presented with a month’s history of worsening abdominal pain. She was pale and had massive splenomegaly. Her blood count showed a white cell count of 66.6 3 10/L, hemoglobin concentration of 80 g/L, and platelet count of 354 3 10/L. The differential count was: neutrophils 16.8 3 10/L, myelocytes 4 3 10/L, lymphocytes 3.8 3 10/L, eosinophils 9.4 3 10/L, basophils 8.1 3 10/L, and blast cells 24.5 3 10/L. The circulating blast cells had weakly basophilic cytoplasm, with some cytoplasmic vacuolation and budding; there were occasional circulating micromegakaryocytes with more condensed chromatin and delicately granular cytoplasm resembling that of a platelet (left). Because of the characteristic differential count, transformed chronic myeloid leukemia was suspected. A bone marrow aspirate showed active granulopoiesis. There were 34% blast cells, which were cytologically similar to those in the peripheral blood. Micromegakaryocytes constituted 24% of nucleated cells. Many of these were very distinctive, being lymphocyte-sized with condensed chromatin and with cytoplasm fragmenting into platelets (right). Cytogenetic analysis showed 46,XX,t(9;22)(q34;q11.2)[3]/46,XX,add(7)(p15), t(9;22)(q34;q11.2)[18]/46,XX[1], confirming the diagnosis of transformed chronic myeloid leukemia with clonal evolution. Fluorescence in situ hybridization (FISH) using a Vysis (Abbott) dual fusion probe found 100% of the cells scored to have BCR-ABL1 and ABL1-BCR fusions, with 20% having duplicated fusion signals. Immunophenotyping showed the blast cells to be negative for myeloperoxidase. In the chronic phase of chronic myeloid leukemia, megakaryocytes are smaller than normal but micromegakaryocytes are not a feature. However when megakaryoblastic/megakaryocytic transformation occurs, micromegakaryocytes are often numerous and lymphocyte-sized micromegakaryocytes with active platelet production are particularly characteristic.
What problem does this paper attempt to address?